Acquired by Quidel Corp. Diagnostic HYBRIDS, Inc. develops, manufactures, and markets cellular and molecular diagnostic kits for various applications in detecting a range of respiratory diseases, herpes infections, thyroid function, and other markers of diseases. The company also develops and commercializes genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry with a focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. In addition, the company provides an assortment of products for specimen collection, specimen transport, multi-virus cell culture amplification, and sensitive and specific virus detection using monoclonal antibody kits and reagents. Diagnostic HYBRIDS, Inc. was incorporated in 1982 and is based in Athens, Ohio. Diagnostic HYBRIDS, Inc. operates as a subsidiary of Quidel Corp.
View Website: http://www.quidel.com/